White Matter Hyperintensities in Parkinson's Disease: Do They Explain the Disparity between the Postural Instability Gait Difficulty and Tremor Dominant Subtypes?

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Herman, Talia ^a,b   Rosenberg Katz, Keren ^a   Jacob, Yael ^a   Auriel, Eitan ^a   Gurevich, Tanya ^a   Giladi, Nir ^a,b   Hausdorff, Jeffrey M ^a,b,c  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BODY POSTURE; BRAIN REGION; CLINICAL EVALUATION; CLINICAL FEATURE; CORRELATION ANALYSIS; DEPRESSION; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; GAIT DISORDER; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PATIENT CODING; QUANTITATIVE ANALYSIS; RATING SCALE; RISK FACTOR; TREMOR; UNIFIED PARKINSON DISEASE RATING SCALE; WHITE MATTER;

ADULT; AGED; AGED, 80 AND OVER; GAIT ATAXIA; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; MYELIN SHEATH; PARKINSON DISEASE; POSTURAL BALANCE; TREMOR;

EID: 84873188990     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055193     Document Type: Article

References (104)

1. Jankovic J, (2008) Parkinson's disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry 79: 368-76.
2. Jankovic J, McDermott M, Carter J, Gauthier S, Goetz C, et al. (1990) Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology 40: 1529-34.
3. van Rooden SM, Colas F, Martinez-Martin P, Visser M, Verbaan D, et al. (2011) Clinical subtypes of Parkinson's disease. Mov Disord 26: 51-8.
4. Selikhova M, Williams DR, Kempster PA, Holton JL, Revesz T, et al. (2009) A clinico-pathological study of subtypes in Parkinson's disease. Brain 132: 2947-57.
5. Murray ME, Senjem ML, Petersen RC, Hollman JH, Preboske GM, et al. (2010) Functional impact of white matter hyperintensities in cognitively normal elderly subjects. Arch Neurol 67: 1379-85.
6. Benson RR, Guttmann CR, Wei X, Warfield SK, Hall C, et al. (2002) Older people with impaired mobility have specific loci of periventricular abnormality on MRI. Neurology 58: 48-55.
7. Soumare A, Elbaz A, Zhu Y, Maillard P, Crivello F, et al. (2009) White matter lesions volume and motor performances in the elderly. Ann Neurol 65: 706-15.
8. Baezner H, Blahak C, Poggesi A, Pantoni L, Inzitari D, et al. (2008) Association of gait and balance disorders with age-related white matter changes: the LADIS study. Neurology 70: 935-42.
9. Blahak C, Baezner H, Pantoni L, Poggesi A, Chabriat H, et al. (2009) Deep frontal and periventricular age related white matter changes but not basal ganglia and infratentorial hyperintensities are associated with falls: cross sectional results from the LADIS study. J Neurol Neurosurg Psychiatry 80: 608-13.
10. Franch O, Calandre L, Alvarez-Linera J, Louis ED, Bermejo-Pareja F, et al. (2009) Gait disorders of unknown cause in the elderly: Clinical and MRI findings. J Neurol Sci 280: 84-6.
11. Novak V, Haertle M, Zhao P, Hu K, Munshi M, et al. (2009) White matter hyperintensities and dynamics of postural control. Magn Reson Imaging 27: 752-9.
12. Wolfson L, Wei X, Hall CB, Panzer V, Wakefield D, et al. (2005) Accrual of MRI white matter abnormalities in elderly with normal and impaired mobility. J Neurol Sci 232: 23-7.
13. de Laat KF, Tuladhar AM, van Norden AG, Norris DG, Zwiers MP, et al. (2011) Loss of white matter integrity is associated with gait disorders in cerebral small vessel disease. Brain 134: 73-83.
14. Baloh RW, Vinters HV, (1995) White matter lesions and disequilibrium in older people. II. Clinicopathologic correlation. Arch Neurol 52: 975-81.
15. Bohnen NI, Albin RL, (2011) White matter lesions in Parkinson disease. Nat Rev Neurol 7: 229-36.
16. Gunning-Dixon FM, Raz N, (2000) The cognitive correlates of white matter abnormalities in normal aging: a quantitative review. Neuropsychology 14: 224-32.
17. Hedden T, Van Dijk KR, Shire EH, Sperling RA, Johnson KA et al. (2011) Failure to Modulate Attentional Control in Advanced Aging Linked to White Matter Pathology. Cereb Cortex.
18. Silbert LC, Nelson C, Howieson DB, Moore MM, Kaye JA, (2008) Impact of white matter hyperintensity volume progression on rate of cognitive and motor decline. Neurology 71: 108-13.
19. Prins ND, van Dijk EJ, den HT, Vermeer SE, Jolles J, et al. (2005) Cerebral small-vessel disease and decline in information processing speed, executive function and memory. Brain 128: 2034-41.
20. Tullberg M, Fletcher E, DeCarli C, Mungas D, Reed BR, et al. (2004) White matter lesions impair frontal lobe function regardless of their location. Neurology 63: 246-53.
21. Dubois B, Pillon B, (1997) Cognitive deficits in Parkinson's disease. J Neurol 244: 2-8.
22. Verbaan D, Marinus J, Visser M, van Rooden SM, Stiggelbout AM, et al. (2007) Cognitive impairment in Parkinson's disease 14. J Neurol Neurosurg Psychiatry 78: 1182-7.
23. Cameron IG, Watanabe M, Pari G, Munoz DP, (2010) Executive impairment in Parkinson's disease: response automaticity and task switching. Neuropsychologia 48: 1948-57.
24. Hausdorff JM, Doniger GM, Springer S, Yogev G, Giladi N, et al. (2006) A common cognitive profile in elderly fallers and in patients with Parkinson's disease: the prominence of impaired executive function and attention. Exp Aging Res 32: 411-29.
25. Beyer MK, Aarsland D, Greve OJ, Larsen JP, (2006) Visual rating of white matter hyperintensities in Parkinson's disease. Mov Disord 21: 223-9.
26. Beyer MK, Janvin CC, Larsen JP, Aarsland D, (2007) A magnetic resonance imaging study of patients with Parkinson's disease with mild cognitive impairment and dementia using voxel-based morphometry. J Neurol Neurosurg Psychiatry 78: 254-9.
27. Bohnen NI, Albin RL, (2011) White matter lesions in Parkinson disease. Nat Rev Neurol 7: 229-36.
28. Choi SA, Evidente VG, Caviness JN, Shill HA, Sabbagh MN, et al. (2010) Are there differences in cerebral white matter lesion burdens between Parkinson's disease patients with or without dementia? Acta Neuropathol 119: 147-9.
29. Slawek J, Wieczorek D, Derejko M, Dubaniewicz M, Brockhuis B, et al. (2008) The influence of vascular risk factors and white matter hyperintensities on the degree of cognitive impairment in Parkinson's disease. Neurol Neurochir Pol 42: 505-12.
30. Slawek J, Roszmann A, Robowski P, Dubaniewicz M, Sitek EJ et al. (2012) The Impact of MRI White Matter Hyperintensities on Dementia in Parkinson's Disease in Relation to the Homocysteine Level and Other Vascular Risk Factors. Neurodegener Dis.
31. Green J, McDonald WM, Vitek JL, Evatt M, Freeman A, et al. (2002) Cognitive impairments in advanced PD without dementia. Neurology 59: 1320-4.
32. Rodriguez-Ferreiro J, Cuetos F, Herrera E, Menendez M, Ribacoba R, (2010) Cognitive impairment in Parkinson's disease without dementia. Mov Disord 25: 2136-41.
33. Giladi N, Herman T, Reider-Groswasser II, Gurevich T, Hausdorff JM, (2005) Clinical characteristics of elderly patients with a cautious gait of unknown origin. J Neurol 252: 300-6.
34. Giladi N, Huber-Mahlin V, Herman T, Hausdorff JM, (2007) Freezing of gait in older adults with high level gait disorders: association with impaired executive function. J Neural Transm 114: 1349-53.
35. Gurevich T, Giladi N, (2003) Freezing of gait in multiple system atrophy (MSA). Parkinsonism Relat Disord 9: 169-74.
36. Herman T, Giladi N, Gurevich T, Hausdorff JM, (2005) Gait instability and fractal dynamics of older adults with a "cautious" gait: why do certain older adults walk fearfully? Gait Posture 21: 178-85.
37. Huber-Mahlin V, Giladi N, Herman T, Perez C, Gurevich T, et al. (2010) Progressive nature of a higher level gait disorder: a 3-year prospective study. J Neurol 257: 1279-86.
38. Stolze H, Kuhtz-Buschbeck JP, Drucke H, Johnk K, Illert M, et al. (2001) Comparative analysis of the gait disorder of normal pressure hydrocephalus and Parkinson's disease. J Neurol Neurosurg Psychiatry 70: 289-97.
39. Poggesi A, Pracucci G, Chabriat H, Erkinjuntti T, Fazekas F, et al. (2008) Urinary complaints in nondisabled elderly people with age-related white matter changes: the Leukoaraiosis And DISability (LADIS) Study. J Am Geriatr Soc 56: 1638-43.
40. Verbaan D, Marinus J, Visser M, van Rooden SM, Stiggelbout AM, et al. (2007) Cognitive impairment in Parkinson's disease 14. J Neurol Neurosurg Psychiatry 78: 1182-7.
41. Verbaan D, Marinus J, Visser M, van Rooden SM, Stiggelbout AM, et al. (2007) Patient-reported autonomic symptoms in Parkinson disease. Neurology 69: 333-41.
42. Bohnen NI, Muller ML, Zarzhevsky N, Koeppe RA, Bogan CW, et al. (2011) Leucoaraiosis, nigrostriatal denervation and motor symptoms in Parkinson's disease. Brain 134: 2358-65.
43. Piccini P, Pavese N, Canapicchi R, Paoli C, Del DP, et al. (1995) White matter hyperintensities in Parkinson's disease. Clinical correlations. Arch Neurol 52: 191-4.
44. Stern MB, Braffman BH, Skolnick BE, Hurtig HI, Grossman RI, (1989) Magnetic resonance imaging in Parkinson's disease and parkinsonian syndromes. Neurology 39: 1524-6.
45. Acharya HJ, Bouchard TP, Emery DJ, Camicioli RM, (2007) Axial signs and magnetic resonance imaging correlates in Parkinson's disease. Can J Neurol Sci 34: 56-61.
46. Dalaker TO, Larsen JP, Bergsland N, Beyer MK, Alves G, et al. (2009) Brain atrophy and white matter hyperintensities in early Parkinson's disease(a). Mov Disord 24: 2233-41.
47. Piccini P, Pavese N, Canapicchi R, Paoli C, Del DP, et al. (1995) White matter hyperintensities in Parkinson's disease. Clinical correlations. Arch Neurol 52: 191-4.
48. Stern MB, Braffman BH, Skolnick BE, Hurtig HI, Grossman RI, (1989) Magnetic resonance imaging in Parkinson's disease and parkinsonian syndromes. Neurology 39: 1524-6.
49. Acharya HJ, Bouchard TP, Emery DJ, Camicioli RM, (2007) Axial signs and magnetic resonance imaging correlates in Parkinson's disease. Can J Neurol Sci 34: 56-61.
50. Dalaker TO, Larsen JP, Bergsland N, Beyer MK, Alves G, et al. (2009) Brain atrophy and white matter hyperintensities in early Parkinson's disease(a). Mov Disord 24: 2233-41.
51. Lee SJ, Kim JS, Lee KS, An JY, Kim W, et al. (2009) The severity of leukoaraiosis correlates with the clinical phenotype of Parkinson's disease. Arch Gerontol Geriatr 49: 255-9.
52. Bohnen NI, Muller ML, Zarzhevsky N, Koeppe RA, Bogan CW, et al. (2011) Leucoaraiosis, nigrostriatal denervation and motor symptoms in Parkinson's disease. Brain 134: 2358-65.
53. Hughes AJ, Daniel SE, Kilford L, Lees AJ, (1992) Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55: 181-4.
54. Jankovic J, McDermott M, Carter J, Gauthier S, Goetz C, et al. (1990) Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology 40: 1529-34.
55. Fahn S (1987) Unified Parkinson's disease rating scale. In Fahn S, Marsden CD, Calne D, Goldstein M, editors. Recent developments in Parkinson's disease. Florham Park, NJ: Macmillan Health Care Information. 153-63.
56. Jankovic J, McDermott M, Carter J, Gauthier S, Goetz C, et al. (1990) Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology 40: 1529-34.
57. Jankovic J, McDermott M, Carter J, Gauthier S, Goetz C, et al. (1990) Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology 40: 1529-34.
58. Jankovic J, McDermott M, Carter J, Gauthier S, Goetz C, et al. (1990) Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology 40: 1529-34.
59. Jankovic J, McDermott M, Carter J, Gauthier S, Goetz C, et al. (1990) Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology 40: 1529-34.
60. Jankovic J, McDermott M, Carter J, Gauthier S, Goetz C, et al. (1990) Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology 40: 1529-34.
61. Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, et al. (2008) Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 23: 2129-70.
62. Nieuwboer A, Rochester L, Herman T, Vandenberghe W, Emil GE et al. (2009) Reliability of the new freezing of gait questionnaire: Agreement between patients with Parkinson's disease and their carers. Gait Posture.
63. Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, et al. (2005) The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53: 695-9.
64. Folstein MF, Folstein SE, McHugh PR, (1975) "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189-98.
65. de Laat KF, Tuladhar AM, van Norden AG, Norris DG, Zwiers MP, et al. (2011) Loss of white matter integrity is associated with gait disorders in cerebral small vessel disease. Brain 134: 73-83.
66. Silbert LC, Nelson C, Howieson DB, Moore MM, Kaye JA, (2008) Impact of white matter hyperintensity volume progression on rate of cognitive and motor decline. Neurology 71: 108-13.
67. Petrovic IN, Stefanova E, Kozic D, Semnic R, Markovic V, Daragasevic N, Kostic V. White matter lesions and depression in patients with Parkinson's disease. In 2012.
68. Sneed JR, Culang-Reinlieb ME, (2011) The vascular depression hypothesis: an update. Am J Geriatr Psychiatry 19: 99-103.
69. Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, et al. (1982) Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 17: 37-49.
70. Scheltens P, Barkhof F, Leys D, Pruvo JP, Nauta JJ, et al. (1993) A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. J Neurol Sci 114: 7-12.
71. Kapeller P, Barber R, Vermeulen RJ, Ader H, Scheltens P, et al. (2003) Visual rating of age-related white matter changes on magnetic resonance imaging: scale comparison, interrater agreement, and correlations with quantitative measurements. Stroke 34: 441-5.
72. Gouw AA, van der Flier WM, van Straaten EC, Pantoni L, Bastos-Leite AJ, et al. (2008) Reliability and sensitivity of visual scales versus volumetry for evaluating white matter hyperintensity progression. Cerebrovasc Dis 25: 247-53.
73. van Straaten EC, Fazekas F, Rostrup E, Scheltens P, Schmidt R, et al. (2006) Impact of white matter hyperintensities scoring method on correlations with clinical data: the LADIS study. Stroke 37: 836-40.
74. Beyer MK, Aarsland D, Greve OJ, Larsen JP, (2006) Visual rating of white matter hyperintensities in Parkinson's disease. Mov Disord 21: 223-9.
75. Scheltens P, Barkhof F, Leys D, Pruvo JP, Nauta JJ, et al. (1993) A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. J Neurol Sci 114: 7-12.
76. Bokde AL, Teipel SJ, Schwarz R, Leinsinger G, Buerger K, et al. (2005) Reliable manual segmentation of the frontal, parietal, temporal, and occipital lobes on magnetic resonance images of healthy subjects. Brain Res Brain Res Protoc 14: 135-45.
77. Bohnen NI, Muller ML, Zarzhevsky N, Koeppe RA, Bogan CW, et al. (2011) Leucoaraiosis, nigrostriatal denervation and motor symptoms in Parkinson's disease. Brain 134: 2358-65.
78. Lee SJ, Kim JS, Lee KS, An JY, Kim W, et al. (2009) The severity of leukoaraiosis correlates with the clinical phenotype of Parkinson's disease. Arch Gerontol Geriatr 49: 255-9.
79. Acharya HJ, Bouchard TP, Emery DJ, Camicioli RM, (2007) Axial signs and magnetic resonance imaging correlates in Parkinson's disease. Can J Neurol Sci 34: 56-61.
80. Dalaker TO, Larsen JP, Bergsland N, Beyer MK, Alves G, et al. (2009) Brain atrophy and white matter hyperintensities in early Parkinson's disease(a). Mov Disord 24: 2233-41.
81. Smart SD, Firbank MJ, O'Brien JT, (2011) Validation of automated white matter hyperintensity segmentation. J Aging Res 2011: 391783.
82. Bohnen NI, Muller ML, Zarzhevsky N, Koeppe RA, Bogan CW, et al. (2011) Leucoaraiosis, nigrostriatal denervation and motor symptoms in Parkinson's disease. Brain 134: 2358-65.
83. Jankovic J, McDermott M, Carter J, Gauthier S, Goetz C, et al. (1990) Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology 40: 1529-34.
84. Kassubek J, Juengling FD, Hellwig B, Spreer J, Lucking CH, (2002) Thalamic gray matter changes in unilateral Parkinsonian resting tremor: a voxel-based morphometric analysis of 3-dimensional magnetic resonance imaging. Neurosci Lett 323: 29-32.
85. Zaidel A, Arkadir D, Israel Z, Bergman H, (2009) Akineto-rigid vs. tremor syndromes in Parkinsonism. Curr Opin Neurol 22: 387-93.
86. van Straaten EC, Fazekas F, Rostrup E, Scheltens P, Schmidt R, et al. (2006) Impact of white matter hyperintensities scoring method on correlations with clinical data: the LADIS study. Stroke 37: 836-40.
87. Zheng JJ, Delbaere K, Close JC, Sachdev PS, Wen W et al. (2011) White matter hyperintensities and impaired choice stepping reaction time in older people. Neurobiol Aging.
88. Zheng JJ, Delbaere K, Close JC, Sachdev PS, Lord SR, (2011) Impact of white matter lesions on physical functioning and fall risk in older people: a systematic review. Stroke 42: 2086-90.
89. Bohnen NI, Muller ML, Zarzhevsky N, Koeppe RA, Bogan CW, et al. (2011) Leucoaraiosis, nigrostriatal denervation and motor symptoms in Parkinson's disease. Brain 134: 2358-65.
90. de Leeuw FE, de Groot JC, Achten E, Oudkerk M, Ramos LM, et al. (2001) Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study. J Neurol Neurosurg Psychiatry 70: 9-14.
91. Pantoni L, Poggesi A, Basile AM, Pracucci G, Barkhof F, et al. (2006) Leukoaraiosis predicts hidden global functioning impairment in nondisabled older people: the LADIS (Leukoaraiosis and Disability in the Elderly) Study. J Am Geriatr Soc 54: 1095-101.
92. Jankovic J, McDermott M, Carter J, Gauthier S, Goetz C, et al. (1990) Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology 40: 1529-34.
93. Lee SJ, Kim JS, Lee KS, An JY, Kim W, et al. (2009) The severity of leukoaraiosis correlates with the clinical phenotype of Parkinson's disease. Arch Gerontol Geriatr 49: 255-9.
94. Zheng JJ, Delbaere K, Close JC, Sachdev PS, Lord SR, (2011) Impact of white matter lesions on physical functioning and fall risk in older people: a systematic review. Stroke 42: 2086-90.
95. Blahak C, Baezner H, Pantoni L, Poggesi A, Chabriat H, et al. (2009) Deep frontal and periventricular age related white matter changes but not basal ganglia and infratentorial hyperintensities are associated with falls: cross sectional results from the LADIS study. J Neurol Neurosurg Psychiatry 80: 608-13.
96. Annweiler C, Montero-Odasso M, (2012) Vascular burden as a substrate for higher-level gait disorders in older adults. A review of brain mapping literature. Panminerva Med 54: 189-204.
97. Kassubek J, Juengling FD, Hellwig B, Spreer J, Lucking CH, (2002) Thalamic gray matter changes in unilateral Parkinsonian resting tremor: a voxel-based morphometric analysis of 3-dimensional magnetic resonance imaging. Neurosci Lett 323: 29-32.
98. Benninger DH, Thees S, Kollias SS, Bassetti CL, Waldvogel D, (2009) Morphological differences in Parkinson's disease with and without rest tremor. J Neurol 256: 256-63.
99. Kostic VS, Agosta F, Pievani M, Stefanova E, Jecmenica-Lukic M, et al. (2012) Pattern of brain tissue loss associated with freezing of gait in Parkinson disease. Neurology 78: 409-16.
100. Healy DG, Falchi M, O'Sullivan SS, Bonifati V, Durr A, et al. (2008) Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study. Lancet Neurol 7: 583-90.
101. Marras C, Schule B, Munhoz RP, Rogaeva E, Langston JW, et al. (2011) Phenotype in parkinsonian and nonparkinsonian LRRK2 G2019S mutation carriers. Neurology 77: 325-33.
102. Alcalay RN, Mejia-Santana H, Tang MX, Rosado L, Verbitsky M, et al. (2009) Motor phenotype of LRRK2 G2019S carriers in early-onset Parkinson disease. Arch Neurol 66: 1517-22.
103. Vaillancourt DE, Spraker MB, Prodoehl J, Abraham I, Corcos DM, et al. (2009) High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease. Neurology 72: 1378-84.
104. Gattellaro G, Minati L, Grisoli M, Mariani C, Carella F, et al. (2009) White matter involvement in idiopathic Parkinson disease: a diffusion tensor imaging study. AJNR Am J Neuroradiol 30: 1222-6.